177Lu-DOTATATE in neuroendocrine tumors: Real-world evidence of efficacy and safety in a community setting

被引：0
|
作者：
Sassic, Jessica
Farasat, Sadaf
Hermel, David
Sigal, Darren
Xavier, Marin Feldman
机构：
[1] Scripps Mercy Hosp, San Diego, CA USA
[2] Scripps Green Hosp, Scripps Clin, La Jolla, CA USA
[3] Scripps Clin, La Jolla, CA USA
[4] Scripps Clin, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16249
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Dosimetry of 177Lu-DOTATATE administered into neuroendocrine tumors - An initial experience from India
    Gupta, Santosh
    Meera, V
    Malhotra, A.
    Kumar, Prateek
    Bal, Chandersekhar
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [42] Predictive factors of persistent thrombocytopenia after 177Lu-DOTATATE in patients with neuroendocrine tumors
    Oziel-Taieb, S.
    Ferrara, R.
    Charrier, N.
    Maniry, J.
    Reichert, T.
    Brenot-Rossi, I
    Niccoli, P.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 213 - 213
  • [43] Salvage 177Lu-dotatate therapy in patients with progressive metastatic neuroendocrine tumors.
    Hoe, Hui Jing
    Wyld, David
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16212 - E16212
  • [44] Safety of 177Lu-DOTATATE in Patients With Advanced Neuroendocrine Tumors: Data From a US Expanded Access Program
    Allen-Auerbach, M.
    Wolin, E.
    Nassiri, V.
    Broberg, P.
    El-Haddad, G.
    PANCREAS, 2021, 50 (03) : 453 - 453
  • [45] Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors
    Zandee, Wouter T.
    Brabander, Tessa
    Blazevic, Anela
    Kam, Boen L. R.
    Teunissen, Jaap J. M.
    Feelders, Richard A.
    Hofland, Johannes
    de Herder, Wouter W.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (04): : 1336 - 1344
  • [46] Therapy With 177Lu-DOTATATE: Clinical Implementation and Impact on Care of Patients With Neuroendocrine Tumors
    Kendi, A. Tuba
    Halfdanarson, Thorvardur R.
    Packard, Annie
    Dundar, Ayca
    Subramaniam, Rathan M.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 213 (02) : 309 - 317
  • [47] Evaluation of 177Lu-Dotatate treatment in patients with metastatic neuroendocrine tumors and prognostic factors
    Abou Jokh Casas, Estephany
    Pubul Nunez, Virginia
    Anido-Herranz, Urbano
    Mallon Araujo, Maria del Carmen
    Pombo Pasin, Maria del Carmen
    Pumar, Miguel Garrido
    Cabezas Agricola, Jose Manuel
    Manuel Cameselle-Teijeiro, Jose
    Hilal, Ashraf
    Ruibal Morell, Alvaro
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (13) : 1513 - 1524
  • [48] Evaluation of 177Lu-Dotatate treatment in patients with metastatic neuroendocrine tumors and prognostic factors
    Estephany Abou Jokh Casas
    Virginia Pubul Nú?ez
    Urbano Anido-Herranz
    María del Carmen Mallón Araujo
    Maria del Carmen Pombo Pasín
    Miguel Garrido Pumar
    José Manuel Cabezas Agrícola
    José Manuel Cameselle-Teijeiro
    Ashraf Hilal
    álvaro Ruibal Morell
    World Journal of Gastroenterology, 2020, 26 (13) : 1513 - 1524
  • [49] Efficacy and safety of 177Lu-DOTATATE targeted therapy in advanced/metastatic pulmonary neuroendocrine tumors: A systematic review and meta-analysis
    Ma, Jiao
    Hu, Xin
    Li, Lanying
    Rao, Zijuan
    Zhang, Chunyin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [50] Receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumours
    Bodei, L.
    Cremonesi, M.
    Grana, C.
    Bartolomei, M.
    Baio, S.
    Bufi, G.
    Fiorenza, M.
    Obenaus, E.
    Paganelli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S214 - S214
12345